← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Nectagen, Inc.
Lawrence, KS
$1,649,265
Total funding
9
Grants
Funding over time
peak $299.9K · FY2010–24$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,649,265 · 9
By mechanism
R43$1,074,915 · 6
N43$299,850 · 2
R41$274,500 · 1
Investigators at Nectagen, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Development of Custom nanoCLAMP Affinity Chromatography Resins for Fast, Efficient Purification of Plasma Proteins$275,000
R43 · FY2024 · TR
Development of an Orally Available Therapeutic for Neutralizing C. difficile Toxin B$274,500
R41 · FY2023 · AI
Development of DNA-Labeled Antibody Mimetics as Low-Cost, High-Performance Reagents for Single Cell Analysis of Membrane Proteins$252,484
R43 · FY2021 · GM
Generation of High Resolution Antibody Mimetics to Improve the Visualization of Subcellular Structures by Super Resolution Microscopy$150,000
R43 · FY2018 · GM
Development of Enzyme Replacement Therapy for Complement C2-Deficiency$150,000
R43 · FY2019 · AI
SBIR TOPIC 294 PHASE I - DEVELOPMENT OF GLYCOSYLATION - SPECIFIC RESEARCH$149,993
N43 · FY2011 · CA
Affinity reagents for the sub-fractionation of specific exosomal populations$149,931
R43 · FY2018 · GM
TAS::75 0849::TAS DEVELOPMENT OF ALTERNATIVE AFFINITY CAPTURE REAGENTS FOR CANCE$149,857
N43 · FY2010 · CA
High-Throughput Low Cost Production of Chromatin-Immunoprecipitation-Grade Antib$97,500
R43 · FY2010 · HG